Magenta Therapeutics (Series A)

Funding Details
Awarder
Inbox
Date Award
November 16, 2016
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$48,500,000

Company Info
Founding Year
2016
Founders
Jason Gardner
Company Description
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.
Market
Stem cell transplantation for patients with immune- and blood-based diseases
Location
Cambridge, MA, USA
Coinvestors
Atlas Venture, Third Rock Ventures

Links